Journals / Bozok Tıp Dergisi / 2019 / Cilt: 9 - Sayı: 4

Comparison of Chronic Low Dose Gonadotropin and Conventional Dose Gonadotropin Treatment Protocols in Patients Who Had Clomiphene Citrate-Resistant Anovulation Associated With Polycystic Ovarian Syndrome

KLOMİFEN SİTRATA REZİSTAN OLAN POLİKİSTİK OVER SENDROMLU OLGULARDA KRONİK DÜŞÜK DOZ GONADOTROPİN VE KONVANSİYONEL DOZ GONADOTROPİN TEDAVİ PROTOKOLLERİNİN KARŞILAŞTIRILMASI

Pages
156–161
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The use of chronic low-dose regimen of FSH permitted induction of ovulation safely by minimizing the risk of multifollicular development and OHSS while maintaining a satisfactory pregnancy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare efficiency of conventional and chronic low-dose regimens for treatment of anovulation associated with polycystic ovary syndrome (PCOS).
📊
Key Findings & Data:Materials and methods: Fifty women, who had clomiphene citrate-resistant anovulation associated with PCOS, participated in the study.
💡
Conclusion & Impact:Conclusion: The use of chronic low-dose regimen of FSH permitted induction of ovulation safely by minimizing the risk of multifollicular development and OHSS while maintaining a satisfactory pregnancy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To compare efficiency of conventional and chronic low-dose regimens for treatment of anovulation associated with polycystic ovary syndrome (PCOS). Materials and methods: Fifty women, who had clomiphene citrate-resistant anovulation associated with PCOS, participated in the study. The first 25 patients were treated with urinary FSH using a conventional stepwise protocol (Group 1), while the second group had a regimen of chronic low dose FSH (Group 2). Patterns of follicular development, amount of FSH required, serum estradiol concentrations, cycle fecundity, rates of multiple pregnancy and OHSS were compared. Results: The two groups were similar in terms of duration of infertility, age, body mass index and endocrine parameters. The duration of treatment was significantly higher (p = 0.02) in Group 2 . The percentage of ovulatory cycles occurring in low dose and conventional regimens was 68% versus 76% respectively. Pregnancy rate was 20% in conventional stepwise protocol group and 24% in chronic low dose group. The patients in Group 2 had a higher pregnancy rate per ovulatory cycle (37% versus 26%). Monofollicular development was noted in 60% of the Group 2 patients (48% in Group 1, p = 0.03). Treatment with the low-dose protocol resulted in significant reduction in OHSS (p < 0.04) and serum oestradiol concentrations (p < 0.008). No multiple pregnancies occurred in either group. Conclusion: The use of chronic low-dose regimen of FSH permitted induction of ovulation safely by minimizing the risk of multifollicular development and OHSS while maintaining a satisfactory pregnancy

Özet

Amaç: Anovulatuar polikistik over sendromlu hastalarda kronik düşük doz ve konvansiyonel doz tedavi rejimlerinin etkinliklerinin karşılaştırılmasıGereç ve yöntemler: Klomifen sitrata rezistan anovulatuar PCOS tanısı almış olan 50 olgu çalışmaya dahiledildi. Olguların 25 tanesine konvansiyonel stepwise protokol uygulandı ve (Grup 1) olarak adlandırıldı. Diğer 25 olgudan oluşan gruba (Grup 2)’ da kronik düşük doz FSH protokol uygulandı. Hastalar seri ultrasonografi ve serum estradiol sevilerine bakılarak monitörize edildi. Folliküler gelişim paterni, toplam kullanılanFSH dozu, serum estradiol konsantrasyonu, siklus fekunditesi, multiple gebelik oranları ve ovarian hiperstimulasyon sendromu açısından iki grup karşılaştırıldı.Bulgular: Her iki grup yaş, infertilite süresi, vücut kitle indeksi ve endokrin parametreler açısından benzerolarak bulundu. Stimulasyon süresi Grup 2 'de anlamlı olarak uzun bulundu (p=0.02). Gruplar, ovulatuarsiklus açısından değerlendirildiğinde düşük doz kullanılan grupta ovulatuar siklus oranı %68 iken konvansiyonel grupta %76 olarak bulundu. Gebelik oranları açısından değerlendirildiğinde düşük doz grupta gebelikoranı %24 iken konvansiyonel grupta %20 olarak bulundu. Düşük doz kullanılan grupta ovulatuar siklus başına gebelik oranı konvansiyonel gruptan daha yüksek (%37 vs %26) idi. Monofolliküler gelişim düşük dozkullanılan grupta %60, konvansiyonel grupta ise %48 olarak bulundu. Düşük doz kullanılan grupta gerekOHSS (p < 0.04) gerekse estradiol (p < 0.008) konsantrasyonları anlamlı olarak düşük bulundu. Her iki gruptada çoğul gebelik izlenmedi.Sonuç: Kronik düşük doz FSH rejimi ; multifolliküler gelişim ve OHSS riskini azaltarak, ovulasyon indüksiyonunun güvenliğini artırmakta ve bunun yanında tatmin edici gebelik sonuçları elde edilmesini sağlayabilmektedir.

🔖

Cite This Article

DİLBAZ, B., ÖZELÇ, R. K. (2022). Comparison of Chronic Low Dose Gonadotropin and Conventional Dose Gonadotropin Treatment Protocols in Patients Who Had Clomiphene Citrate-Resistant Anovulation Associated With Polycystic Ovarian Syndrome. Bozok Tıp Dergisi, Cilt: 9 - Sayı: 4, 156–161. https://ajindex.com/articles/468525

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Carvalho LML, Dos Reis FM, Candido AL, Nunes FFC, Ferreira CN, Gomes KB. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review. Endocr Regul. 2018 Oct 1
  2. 52(4):208-221 2. Ajmal N, Khan ZS, Shaikh R. Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article. Eur J Obstet Gynecol Reprod Biol X: X 2019
  3. 3 3. Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol. 2004
  4. BelenkaiaLV, Lazareva LM, Walker W, Lizneva DV, Suturina LV. Criteria, phenotypes and prevalence of polycystic ovary syndrome. Minerva Ginecol. 2019 Jun
  5. 71 (3):211-223 5. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol. 2004
  6. 60(1):1-17. 6. Diamanti-Kandarakis E, Piperi C, Spina J Argyrakopoulou G, Papanastasiou L, Bergiele A, Polycystic ovary syndrome: The influence of environmental and genetic factors. Hormones. 2006
  7. 5(1):17-34. 7. Amer SA, Li TC, Metwally M, Emarh M, Ledger WL. Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first-line method of ovulation induction in women with polycystic ovary syndrome. Hum Reprod. 2009
  8. 24 (1):219-25. 8. Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Comparison of Clinical, Metabolic, Hormonal, and Ultrasound Parameters among the Clomiphene Citrate-Resistant and Clomiphene CitrateSensitive Polycystic Ovary Syndrome Women. J Hum Reprod Sci. 2019 Jul-Sep
  9. 12(3):216-223. 9. Alshahrani S, Aldossari K, Al-Zahrani J, Gabr AH,, Henkel R, Ahmad G. Interpretation of semen analysis using WHO 1999 and WHO 2010 reference values: Abnormal becoming normal. Andrologia. 2018 Mar
  10. 50(2) 10. Brown JB. Pituitary control of ovarian function concepts derived from gonadotropin therapy.Aust NZJ Obstet Gynecol. 1978
  11. 47 11. Petersen KB, Pedersen NG, Pedersen AT, Lauritsen MP, Freiesleben NC. Mono-ovulation in women with polycystic ovary syndrome: a clinical review onovulation induction. RBM Online. 2016
  12. 32, 563–583 12. VTN Lan, RJ Norman, GH Nhu, PH Tuan, HM Tuong. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome. RBM Online. 2009 Vol 18. No 4 516-521 13. Sagle MA, Hamilton-Fairley DH, Kiddy D, Franks S.A. Comperative randomized study of low-dose human menopausal gonadotropin and follicle stimulating hormone in women with polycystic ovarian syndr